VAP-1 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of VAP-1 monoclonal antibodies for research focused on understanding VAP-1's role in various biological processes. The monoclonal antibodies are validated for multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). VAP-1, or vascular adhesion protein 1, is a crucial molecule involved in the adhesion of leukocytes to endothelial cells, playing a significant role in inflammation and immune response. VAP-1's function is vital in various pathological conditions, including autoimmune diseases and cancer, making it an important target for therapeutic interventions. Understanding the mechanisms of VAP-1 can provide insights into disease progression and potential treatment strategies. Researchers worldwide utilize VAP-1 monoclonal antibodies to investigate cellular pathways and molecular interactions. Advanced research techniques and protocols enable detailed examination of VAP-1 expression patterns and functional characteristics. The specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies support researchers in making meaningful contributions to scientific understanding of VAP-1's role in human health and disease.